• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A new Listeria species from Costa Rica identified

Bioengineer by Bioengineer
April 17, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Listeria costaricensis is the official name given to the new bacterial species described by investigators from the Costa Rican Institute of Technology (TEC) and the WHO-collaborating center on Listeria at Institut Pasteur.

Listeria is a bacterial genus comprising 18 species. Two of them are pathogenic to humans and animals, upon consumption of contaminated food. Listeria monocytogenes, the best characterized pathogenic species, can cause gastroenteritis, septicemia and central nervous system infection, mostly in immunocompromised individuals, as well as fetal and neonatal infection.

While the new species Listeria costaricensis is non-pathogenic, its characterization will nonetheless increase our understanding of the pathogenic potential of Listeria. "The discovery of Listeria costaricensis will allow comparisons with pathogenic Listeria species, in order to better understand the behavior and adaptations of these bacterial pathogens," explained TEC biotechnologist Kattia Núñez.

Listeria costaricensis was isolated from water collected at an industrial drainage area in the Costa Rican province of Alajuela, after three years of sample collection and research. "In Costa Rica, there have been few studies on microbiological diversity. Our recent finding reflects the biodiversity of Costa Rican soils and suggests that this Central American country is a fertile environment for this type of research," added Javier Pizarro-Cerda, Research Director at the Institut Pasteur, who participated in the study and now heads the Yersinia Research Unit. For Marc Lecuit, head of Biology of Infection Unit at Institut Pasteur and French National Reference Center for Listeria (page in French), this collaboration illustrates the public health and scientific dimensions of the activities of the WHO-collaborating center on Listeria, which assists colleagues from around the world on the characterization of Listeria isolates.

Listeria costaricensis has been registered in the microorganism collections of the Institut Pasteur in Paris and in the DSMZ, in Germany; its description was published in the International Journal of Systematic and Evolutionary Microbiology (30.01.2018, Vol. 68: 844-850). Following this discovery, the Institut Pasteur and TEC, who have been engaged in informal collaborations since 2013, signed a cooperation agreement to facilitate the continuation of collaborative work between the two institutions.

###

Media Contact

Aurelie Perthuison
[email protected]

http://www.pasteur.fr

https://www.pasteur.fr/en/research-journal/news/new-listeria-species-costa-rica-identified

Related Journal Article

http://dx.doi.org/10.1099/ijsem.0.002596

Share12Tweet7Share2ShareShareShare1

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.